Home Cart Sign in  
Chemical Structure| 110044-82-1 Chemical Structure| 110044-82-1

Structure of MG-101
CAS No.: 110044-82-1

Chemical Structure| 110044-82-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MG-101 is a potent inhibitor of cysteine proteases including calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 500 pM).

Synonyms: Calpain inhibitor I; ALLN; AcLLnLCHO, Ac-Leu-Leu-Nle-Aldehyde.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MG-101

CAS No. :110044-82-1
Formula : C20H37N3O4
M.W : 383.53
SMILES Code : O=C(N[C@H](C=O)CCCC)[C@@H](NC([C@@H](NC(C)=O)CC(C)C)=O)CC(C)C
Synonyms :
Calpain inhibitor I; ALLN; AcLLnLCHO, Ac-Leu-Leu-Nle-Aldehyde.
MDL No. :MFCD00065505
InChI Key :FMYKJLXRRQTBOR-BZSNNMDCSA-N
Pubchem ID :443118

Safety of MG-101

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P271-P280

Related Pathways of MG-101

pyroptosis

Isoform Comparison

Biological Activity

Target
  • Cysteine Protease

In Vitro:

Cell Line
Concentration Treated Time Description References
Huh7 cells 80 nM, 0.8 µM, 4 µM, 20 µM, 100 µM 1 hour To evaluate the inhibitory effect of MG-101 on SARS-CoV-2 pseudovirus infection, the results showed that MG-101 significantly inhibited pseudovirus infection with an EC50 value of 3.12 µM. Comput Struct Biotechnol J. 2022;20:2442-2454.
A549 cells 80 nM, 0.8 µM, 4 µM, 20 µM, 100 µM 1 hour To evaluate the inhibitory effect of MG-101 on SARS-CoV-2 pseudovirus infection, the results showed that MG-101 significantly inhibited pseudovirus infection with an EC50 value of 1.15 µM. Comput Struct Biotechnol J. 2022;20:2442-2454.
MiaPaCa-2 cells 5 µM 20 hours To evaluate whether MG-101 mediates proteasomal or lysosomal degradation of Bcl-2, results showed that MG-101 failed to prevent the downregulation of Bcl-2 by PM. Int J Oncol. 2014 May;44(5):1707-15.
Panc-1 cells 5 µM 20 hours To evaluate whether MG-101 mediates proteasomal or lysosomal degradation of Bcl-2, results showed that MG-101 failed to prevent the downregulation of Bcl-2 by PM. Int J Oncol. 2014 May;44(5):1707-15.
Huh-7.5 cells 0.038 µM 24 hours MG-101 inhibits SARS-CoV-2 replication with an EC50 of 0.038 µM Commun Biol. 2022 Feb 25;5(1):169.
HEK293T cells 10 µM 24 hours MG-101 inhibits Mpro activity, reducing protease activity by 50% Commun Biol. 2022 Feb 25;5(1):169.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.04mL

2.61mL

1.30mL

26.07mL

5.21mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories